Lake Street analyst Ben Klieve notes that Q3 results “varied dramatically” from estimates for American Vanguard (AVD) as revenue, gross profit and EBITDA fell “well short” of the firm’s forecasts, though it adds that the “overwhelming majority of this” was attributable to two products – Dacthal and Aztec. On balance, however, the “value proposition is unchanged” despite the “noisy quarter,” as material de-leveraging has begun and the firm expects an earnings trough in 2024 to rebound in 2025. While Q3 results “will not be a catalyst,” the firm believes “conditions exist for a convergence” of drivers that set up the stock as “a potential multi-bagger over the next 12-18 months,” adds the analyst, who keeps a Buy rating and $14 price target on the stock.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVD:
- American Vanguard Reports Q3 2024 Financial Results
- Closing Bell Movers: Live Nation jumps 6% after Q3 earnings beat
- American Vanguard maintains 2024 adjusted EBITDA outlook $40M-$50M
- American Vanguard reports Q3 adjusted EBITDA $1.8M vs. $11.4M last year
- AVD Earnings Report this Week: Is It a Buy, Ahead of Earnings?